Drugs / Polyarginine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT01313533 Comparator | Mar 2015 → Dec 2019 | atherosclerosis | St. Luke's Hospital, Chesterfield, Missouri | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyarginine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01313533 ↗ |